Why AI Still Falls Short on the Human Genome’s Hidden Logic

Artificial intelligence is being trained to read genomes, but it still cannot reliably explain how human DNA works. The reason matters: the genome is not a simple blueprint, and the regulatory machinery that turns genes on and off is so layered, dynamic and context-dependent that even the most advanced models remain better at prediction than understanding.

That gap is at the heart of a growing debate in biology and AI. New genomic foundation models such as Evo 2, Genos and Google DeepMind’s AlphaGenome are promising tools for making sense of disease risk and gene function, yet researchers say the human genome behaves less like a codebook than a constantly shifting three-dimensional system of control. The deeper scientists look, the more they find that DNA’s meaning depends on timing, location, cell type and molecular context.

The Human Genome Project delivered a near-complete sequence of human DNA more than two decades ago, but that achievement answered only part of the question. The challenge now is not simply listing genes. It is understanding how they are regulated, how distant DNA elements communicate, and how cells make decisions from one moment to the next. AI can help identify patterns, but the article of record is blunt: the genome’s logic is far more intricate than an input-output problem.

What the human genome really is — and why that matters

The human genome is best understood as a highly regulated biological system, not a static instruction manual. Its roughly 3 billion DNA letters contain around 20,000 protein-coding genes, but those genes make up only a tiny fraction of the full sequence.

For decades, biology often treated DNA as a master plan. That framing helped scientists make progress, but it also oversimplified the role of the large stretches of DNA that do not directly encode proteins. Those noncoding regions are now known to be central to controlling when genes are used, where they are used and how strongly they are expressed.

According to genome researchers, that shift in perspective is one of the biggest conceptual changes in modern biology. The sequence still matters, but the question has moved from “what does this gene do?” to “how is this gene used inside a living cell?”

Why sequence alone is not enough

Sequence information tells scientists the order of the DNA building blocks, but not the full functional context. The same genetic sequence can behave differently depending on whether it is open or compacted, whether it is near an enhancer, and which proteins are present in the cell at the time.

That means two cells with identical genomes can act very differently. A muscle cell, a neuron and a skin cell all contain the same DNA, yet each runs a different biological program because different sets of genes are active in each one.

Genetic regulation, researchers say, is the real challenge: the genome is not a design drawn once and for all, but a system shaped by evolution, context and constant molecular feedback.

How gene regulation works in complex cells

Gene regulation is the process that determines when a gene is switched on or off. In simple organisms, such as bacteria, that process can be relatively direct. In humans and other complex eukaryotes, the system is far more layered.

A gene usually begins its journey when transcription factors bind to DNA and recruit polymerase, the enzyme that copies DNA into messenger RNA. That mRNA is then translated by ribosomes into protein. But almost every step in that chain is subject to control, and those controls are often combinatorial rather than singular.

Transcription factors do not act alone

In humans, transcription factors rarely operate like one-to-one keys and locks. They often work in groups, interact with one another and behave differently depending on the molecular neighborhood they find themselves in.

That means the same transcription factor might activate gene expression in one cell type and suppress it in another. Biology, in other words, is not governed by a single switch but by many signals integrated at once.

This is one reason scientists describe human gene regulation as more like a logical “AND” system than a simple “OR” system. A gene may be activated only when several conditions are met simultaneously, allowing cells to fine-tune behavior in response to subtle changes in their environment.

Enhancers are crucial — and still poorly mapped

Enhancers are DNA elements that help determine whether a gene will be transcribed. They serve as landing zones for transcription factors and often act as the decisive signal telling polymerase to begin copying a gene.

The problem is that enhancers are numerous, difficult to identify and hard to connect to the genes they regulate. There may be hundreds of thousands or even millions of them in the genome, far more than there are genes, and a single enhancer can influence multiple genes while a single gene can respond to multiple enhancers.

That complexity is one reason genome biologists remain frustrated by how much remains unknown. Even after decades of work, scientists still cannot confidently say where every enhancer is, what every enhancer does or which gene each one controls.

Why 3D genome structure changes everything

The genome is not arranged like a flat line inside the cell. It folds into a highly dynamic three-dimensional structure, and that folding affects which genes can be reached, read and regulated.

When cells are not dividing, chromatin — the mix of DNA and packaging proteins — exists in a loose, tangled form. Some regions are compacted and difficult to access, while others remain open and available for transcription. This physical organization helps determine whether a gene is silent or active.

Scientists increasingly view the genome as a spatial system. That means the distance between two pieces of DNA on the linear sequence may matter less than whether they are brought into contact by folding.

What are chromatin loops?

Chromatin loops are structures that bring distant DNA elements into close proximity. They are created in part by cohesin, a protein complex that can move along DNA and extrude loops as needed.

This matters because many enhancers sit far from the genes they regulate, sometimes millions of DNA letters away. Looping allows those distant elements to physically interact with a target gene despite their separation on the sequence.

The looping process is dynamic, not fixed. It varies from one cell to the next and can change rapidly, meaning that even cells of the same type may not be doing exactly the same thing at the same instant.

What is a condensate?

A condensate is a loose, fluid cluster of molecular components that interact in a highly dynamic way. Scientists once imagined that gene-regulatory proteins formed more rigid machines, but current thinking suggests these assemblies are more like transient molecular gatherings.

These hubs are not stable structures in the traditional sense. Instead, they appear to be constantly assembling, dissolving and rearranging as the cell works through its regulatory tasks.

That fluidity is one more reason the genome resists simple explanation. Even a seemingly identical pair of cells can have different looping patterns, different regulatory hubs and different gene-expression states at any given time.

Why AI models are promising — and limited

AI is attractive because the genome’s complexity is too large for humans to analyze manually at scale. Foundation models trained on vast genomic data can spot patterns that are hard to see with traditional methods, and they may be especially useful in predicting the effects of sequence changes.

That predictive ability could help researchers interpret mutations linked to disease and identify regions of DNA that are likely to matter biologically. In practical terms, AI may become an important tool for genomics, especially in areas where large datasets already exist.

But the models have a built-in limitation. They learn correlations from known data, which means they can succeed even without capturing the underlying biology in a mechanistic way. That is useful for forecasting, but less satisfying for anyone seeking a true explanation of how cells work.

The article’s core argument is that this distinction matters. A black-box model might tell scientists that a DNA variation is associated with a particular outcome, but not why that association exists. In biology, the “why” is often the whole point.

How noncoding DNA complicates the story

Noncoding DNA has moved from being dismissed as filler to being recognized as essential infrastructure. It includes the regulatory parts of the genome that help direct gene activity, along with the sequences that give rise to noncoding RNA molecules.

These noncoding RNAs have multiple jobs. Some silence messenger RNAs before they can be translated into protein. Others help guide molecular machinery or shape the timing of expression in response to changing conditions.

What microRNAs do

MicroRNAs are short RNA molecules that can prevent messenger RNA from being translated into protein. They often do this by recruiting enzymes that degrade the target RNA or modify it so it can no longer be used efficiently.

Like transcription factors, microRNAs often act in combinations. A single microRNA may influence many mRNAs, and one mRNA may be regulated by multiple microRNAs. That overlap gives the system flexibility but also makes it harder to model cleanly.

From a biological standpoint, this is a second checkpoint. A cell may transcribe an mRNA and still choose not to make the protein immediately, or at all, depending on the context.

How splicing changes the final protein

Before an mRNA can be translated, it is usually edited. The spliceosome removes introns, the noncoding sections, and joins exons together to form a mature message.

Splicing is not always uniform. Different cell types can process the same pre-mRNA in different ways, producing distinct protein isoforms with different functions. That means a gene does not always yield a single protein product.

This adds another layer of complexity to the AI challenge. A model that understands the sequence but not the splicing context may miss the real biological outcome.

Why the genome is more like a strange loop than a blueprint

The genome is recursive: many of the molecules that regulate genes are themselves produced by genes. That creates a self-referential system in which the genome acts on its own products while also being shaped by previous regulatory states.

Researchers describing this kind of system often invoke the idea of a strange loop — a structure that refers back to itself and is influenced by its own history. In cells, that history includes chromatin state, epigenetic marks, prior gene activity and changing environmental inputs.

That self-referential quality is one reason biology is so hard to simplify. The genome is not simply a file being read; it is a process continuously reading, editing and responding to itself.

One genome biologist summarized the frustration by noting that, if evolution were not the author, no one would have designed such a system from scratch.

What this means for disease research and medicine

The complexity of gene regulation is not just a theoretical problem. It affects how scientists think about disease, inheritance and precision medicine.

Many diseases arise not from broken genes alone but from disrupted regulation — the wrong gene being turned on, the right one being silenced or a protein being produced at the wrong time or in the wrong cell type. That is especially important in cancer, developmental disorders and complex inherited conditions.

AI tools may help identify these patterns faster than conventional methods, but they will not eliminate the need for experiments. To understand a disease-causing variant, researchers still need to test how it affects enhancer activity, chromatin state, RNA processing and protein production.

• AI can prioritize likely important DNA variants.
• Experimental biology is still needed to prove cause and mechanism.
• Regulation often matters more than protein-coding changes alone.
• Cell type and timing can completely change a mutation’s effect.

How close are we to decoding the genome?

We are closer than ever to mapping the pieces, but still far from fully understanding the system. Scientists have identified many of the major components — genes, enhancers, chromatin structure, epigenetic marks, noncoding RNAs and splicing machinery — yet they still struggle to explain how all of those layers interact in real time.

The problem is not just data volume. It is integration. Each layer of gene regulation influences the others, and the system is highly sensitive to context. Even when researchers know where a regulatory element sits, they may not know when it is active, what factors enable it or how its effects vary across cell types.

That leaves the field in an in-between state. The genome is no longer mysterious in the old sense; it is richly mapped, heavily studied and increasingly measurable. But it is still not fully legible in the way an engineer might hope.

What AI can do next

AI will likely remain important in genomics because it is good at recognizing patterns in massive, messy data. It can help predict gene effects, identify candidate enhancers and suggest which mutations may alter biological function.

Still, the article’s central warning stands: pattern recognition is not the same as understanding. If the genome is a dynamic, multi-layered decision system rather than a straightforward code, then models trained mainly on known outcomes will always have limits.

That does not make AI useless. It makes it a tool with a specific job. The goal for biology is not merely to generate predictions, but to explain the hidden rules that make life work.

Timeline: how genome science got here

The current debate over AI and genomes makes more sense when set against the history of molecular biology.

The bottom line

AI is beginning to transform genomics, but it has not solved the hardest problem. The human genome is not just a string of genetic code; it is a shifting, three-dimensional, self-referential network of control.

That complexity is why understanding biology remains one of science’s most difficult tasks. AI may help map the terrain, but the route through it still has to be worked out by biology itself.